Sweden's Q-linea Q1 net sales fall, consumables sales rise 60%

Q Linea AB

30/04/2026 06:41

Overview

Sweden infection diagnostics firm's Q1 net sales fell yr/yr to SEK 2 mln, while consumables sales rose 60% to SEK 1.4 mln

Q1 adjusted EPS loss narrowed from prior year

Company completed restructuring, delivering annual savings of about SEK 16 mln

Outlook

Q-Linea expects strong visibility for U.S. instrument placements in H2 2026 as contracting concludes

Company anticipates increased U.S. consumables usage in Q2 2026 as more instruments come online

Q-Linea plans to launch a dedicated Isolate Kit for RUO applications in Q3 2026

Result Drivers

CONSUMABLES GROWTH - Co said consumables sales rose as installed base grew and March saw record global shipments, with Italy and the Gulf region as main contributors

COST REDUCTION - Co said transition to fully internal production of consumables at start of year led to significant reduction in cost of goods sold

RESTRUCTURING SAVINGS - Co said completed restructuring delivered annual run-rate savings of over SEK 16 mln, with lower operating expenses visible in Q1

Company press release: ID:nMFN9FmCP5

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Net Sales
SEK 2 mln
Q1 Adjusted EPS
-SEK 1.77
Q1 Net Income
-SEK 33.60 mln
Q1 Adjusted Free Cash Flow
-SEK 30.20 mln
Q1 EBIT
-SEK 35 mln


Analyst Coverage

Wall Street's median 12-month price target for Q linea AB is SEK50.00, about 177% above its April 29 closing price of SEK18.05

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)